DataMeds AI (MEDS) executive Ajjarapu bought 10,000 shares for $130M at $13,000.00
Insider transactions reported
Surendra K Ajjarapu (executive at DataMeds AI Inc., MEDS) reported that they bought 10,000 shares for $130M at $13,000.00 on May 20, 2022. After these transactions the filing shows 222,500 shares held indirectly (Through Sandhya Ajjarapu Revocable Trust of 2007 which Reporting Person controls as trustee).
- Reporting person
- Ajjarapu Surendra K
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| May 20, 2022 | Open-market purchase (P) | Common stock | +10,000 | $13,000.00 | $130M | 222,500 indirect |
Holdings before and after
- Common stock: 212,500 to 222,500 indirect, Through Sandhya Ajjarapu Revocable Trust of 2007 which Reporting Person controls as trustee
Other positions listed
- Common stock: 1,112,516 direct
- Common stock: 212,500 indirect, Through Surendra Ajjarapu Revocable Trust of 2007 which Reporting Person controls as trustee
- Common stock: 675,000 indirect, Through spouse
Transaction codes in this filing
- Open-market purchase:
- Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
FAQ
What did Ajjarapu report in this MEDS Form 4?
Surendra K Ajjarapu (executive at DataMeds AI Inc., MEDS) reported that they bought 10,000 shares for $130M at $13,000.00 on May 20, 2022. After these transactions the filing shows 222,500 shares held indirectly (Through Sandhya Ajjarapu Revocable Trust of 2007 which Reporting Person controls as trustee).
How many MEDS shares does Ajjarapu hold after this filing?
The filing shows 222,500 shares held indirectly (Through Sandhya Ajjarapu Revocable Trust of 2007 which Reporting Person controls as trustee) after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
What does transaction code P mean on an SEC Form 4?
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.
Historical context for MEDS
Earlier insider filings at MEDS
- May 18, 2022SEC Form 4: Fell Donald G. bought $2,520 worth of shares (2,000 units at $1.26), increasing direct ownership by 11% to 19,639 units
- Apr 4, 2022SEC Form 4 filed by Doss Howard A.
- Jun 22, 2021SEC Form 4: PETERSON MICHAEL L sold $4,005 worth of Common stock (900 units at $4.45), decreasing direct ownership by 14% to 5,387 units
- Jun 4, 2021SEC Form 4: Jennings Christine L. was granted 10,912 units of Common stock
- Jun 2, 2021SEC Form 4 filed by Trxade Group, Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
Follow MEDS and get a push notification the moment its next story breaks.